Trastuzumab without chemotherapy in the adjuvant treatment of breast cancer: subgroup results from a large observational study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Trastuzumab without chemotherapy in the adjuvant treatment of breast cancer: subgroup results from a large observational study ; volume:18 ; number:1 ; day:8 ; month:1 ; year:2018 ; pages:1-7 ; date:12.2018
BMC cancer ; 18, Heft 1 (8.1.2018), 1-7, 12.2018
- Keyword
-
Krebs
Onkologie
- Creator
-
Dall, Peter
- Contributor
-
Koch, Thorsten
Göhler, Thomas
Selbach, Johannes
Ammon, Andreas
Eggert, Jochen
Gazawi, Nidal
Rezek, Daniela
Wischnik, Arthur
Hielscher, Carsten
Schleif, Nicolas
Cirrincione, Ursula
Hinke, Axel
Feisel-Schwickardi, Gabriele
SpringerLink (Online service)
- DOI
-
10.1186/s12885-017-3857-5
- URN
-
urn:nbn:de:1111-20180226592
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Dall, Peter
- Koch, Thorsten
- Göhler, Thomas
- Selbach, Johannes
- Ammon, Andreas
- Eggert, Jochen
- Gazawi, Nidal
- Rezek, Daniela
- Wischnik, Arthur
- Hielscher, Carsten
- Schleif, Nicolas
- Cirrincione, Ursula
- Hinke, Axel
- Feisel-Schwickardi, Gabriele
- SpringerLink (Online service)
Other Objects (12)
Efficacy and safety of short course adjuvant trastuzumab combination chemotherapy in breast cancer
Effect of adjuvant trastuzumab treatment in conventional clinical setting: an observational retrospective multicenter Italian study
Pertuzumab/Trastuzumab (Mammakarzinom, adjuvant) : Nutzenbewertung gemäß § 35a SGB V
Trastuzumab-Related Cardiotoxicity in Adjuvant Setting: A Real-World Scenario
Adjuvant Chemotherapy for Epithelial Ovarian Cancer (EOC)
Impact of adjuvant chemotherapy for gliomatosis cerebri
Influenza vaccination in breast cancer patients during subcutaneous trastuzumab in adjuvant setting
Pertuzumab/Trastuzumab (Mammakarzinom, adjuvant) : Nutzenbewertung gemäß § 35a SGB V (Ablauf Befristung); Dossierbewertung
Adjuvant Trastuzumab: Do we finally know how long is not too long?
Pertuzumab plus trastuzumab and chemotherapy for Japanese patients with HER2-positive metastatic gastric or gastroesophageal junction cancer: a subgroup analysis of the JACOB trial
Hepatotoxicity induced by trastuzumab used for breast cancer adjuvant therapy: a case report
Adjuvant Radio-chemotherapy for extrahepatic biliary tract cancers
Efficacy and safety of short course adjuvant trastuzumab combination chemotherapy in breast cancer
Effect of adjuvant trastuzumab treatment in conventional clinical setting: an observational retrospective multicenter Italian study
Pertuzumab/Trastuzumab (Mammakarzinom, adjuvant) : Nutzenbewertung gemäß § 35a SGB V
Trastuzumab-Related Cardiotoxicity in Adjuvant Setting: A Real-World Scenario
Adjuvant Chemotherapy for Epithelial Ovarian Cancer (EOC)
Impact of adjuvant chemotherapy for gliomatosis cerebri
Influenza vaccination in breast cancer patients during subcutaneous trastuzumab in adjuvant setting
Pertuzumab/Trastuzumab (Mammakarzinom, adjuvant) : Nutzenbewertung gemäß § 35a SGB V (Ablauf Befristung); Dossierbewertung
Adjuvant Trastuzumab: Do we finally know how long is not too long?
Pertuzumab plus trastuzumab and chemotherapy for Japanese patients with HER2-positive metastatic gastric or gastroesophageal junction cancer: a subgroup analysis of the JACOB trial
Hepatotoxicity induced by trastuzumab used for breast cancer adjuvant therapy: a case report
Adjuvant Radio-chemotherapy for extrahepatic biliary tract cancers
Efficacy and safety of short course adjuvant trastuzumab combination chemotherapy in breast cancer
Effect of adjuvant trastuzumab treatment in conventional clinical setting: an observational retrospective multicenter Italian study
Pertuzumab/Trastuzumab (Mammakarzinom, adjuvant) : Nutzenbewertung gemäß § 35a SGB V
Trastuzumab-Related Cardiotoxicity in Adjuvant Setting: A Real-World Scenario
Adjuvant Chemotherapy for Epithelial Ovarian Cancer (EOC)
Impact of adjuvant chemotherapy for gliomatosis cerebri
Influenza vaccination in breast cancer patients during subcutaneous trastuzumab in adjuvant setting
Pertuzumab/Trastuzumab (Mammakarzinom, adjuvant) : Nutzenbewertung gemäß § 35a SGB V (Ablauf Befristung); Dossierbewertung
Adjuvant Trastuzumab: Do we finally know how long is not too long?
Pertuzumab plus trastuzumab and chemotherapy for Japanese patients with HER2-positive metastatic gastric or gastroesophageal junction cancer: a subgroup analysis of the JACOB trial
Hepatotoxicity induced by trastuzumab used for breast cancer adjuvant therapy: a case report